- Home
- ICAD vs BRNS Comparison
ICAD vs BRNS Comparison
Compare ICAD & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- BRNS
- Stock Information
- Founded
- ICAD 1984
- BRNS 2016
- Country
- ICAD United States
- BRNS United Kingdom
- Employees
- ICAD N/A
- BRNS N/A
- Industry
- ICAD Medical/Dental Instruments
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- BRNS Health Care
- Exchange
- ICAD Nasdaq
- BRNS Nasdaq
- Market Cap
- ICAD 40.8M
- BRNS 36.7M
- IPO Year
- ICAD 1986
- BRNS 2021
- Fundamental
- Price
- ICAD $1.68
- BRNS $1.04
- Analyst Decision
- ICAD
- BRNS Strong Buy
- Analyst Count
- ICAD 0
- BRNS 2
- Target Price
- ICAD N/A
- BRNS $4.00
- AVG Volume (30 Days)
- ICAD 337.8K
- BRNS 59.3K
- Earning Date
- ICAD 11-13-2024
- BRNS 11-06-2024
- Dividend Yield
- ICAD N/A
- BRNS N/A
- EPS Growth
- ICAD N/A
- BRNS N/A
- EPS
- ICAD N/A
- BRNS N/A
- Revenue
- ICAD $18,940,000.00
- BRNS $14,969,000.00
- Revenue This Year
- ICAD $10.15
- BRNS $1,805.74
- Revenue Next Year
- ICAD $3.75
- BRNS N/A
- P/E Ratio
- ICAD N/A
- BRNS N/A
- Revenue Growth
- ICAD 10.03
- BRNS 106.21
- 52 Week Low
- ICAD $1.18
- BRNS $0.80
- 52 Week High
- ICAD $2.65
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- ICAD 43.66
- BRNS 50.96
- Support Level
- ICAD $1.65
- BRNS $0.80
- Resistance Level
- ICAD $2.13
- BRNS $1.05
- Average True Range (ATR)
- ICAD 0.17
- BRNS 0.13
- MACD
- ICAD -0.00
- BRNS 0.02
- Stochastic Oscillator
- ICAD 6.12
- BRNS 54.44
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.